serabelisib
1 product
1 abstract
1 target
Target
PIK3CAAbstract
Serabelisib, sapanisertib (PIKTOR) and paclitaxel: A combinatorial approach to improve PI3K/mTOR/AKT pathway inhibition and treatment response in solid tumors.Org: Avera Cancer Institute, Sioux Falls, SD, Faeth Therapeutics,